Cognizant's most recent trend suggests a bearish bias. One trading opportunity on Cognizant is a Bear Call Spread using a strike $57.00 short call and a strike $62.00 long call offers a potential 14.94% return on risk over the next 9 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $57.00 by expiration. The full premium credit of $0.65 would be kept by the premium seller. The risk of $4.35 would be incurred if the stock rose above the $62.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Cognizant is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Cognizant is bearish.
The RSI indicator is at 35.19 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Cognizant
How Customers Would Benefit from Hewlett-Packard’s 3D Printing Products
Tue, 28 Jun 2016 17:05:30 GMT
Biogen Selects Cognizant's SmartTrials Platform
Tue, 28 Jun 2016 10:11:02 GMT
noodls – TEANECK, N.J., June 28, 2016/PRNewswire / — Cognizant (NASDAQ: CTSH) today announced that Biogen (NASDAQ: BIIB) has selected Cognizant's SmartTrials™ platform to aggregate and store clinical trial operational …
Biogen Selects Cognizant's SmartTrials Platform
Tue, 28 Jun 2016 10:00:00 GMT
PR Newswire – TEANECK, N.J., June 28, 2016 /PRNewswire/ — Cognizant (CTSH) today announced that Biogen (BIIB) has selected Cognizant's SmartTrials™ platform to aggregate and store clinical trial operational and patient data. Cambridge, Mass.-based Biogen has the leading portfolio of medicines to treat multiple sclerosis (MS) and is at the forefront of neurology research, working to develop novel therapies for conditions with few or no treatment options. The SmartTrials platform provides real-time risk assessment and global clinical trial oversight to help companies reduce risk and improve collaboration, quality and compliance.
Cognizant Technology Solutions Corp. breached its 50 day moving average in a Bullish Manner : CTSH-US : June 21, 2016
Tue, 21 Jun 2016 12:24:16 GMT
Baird Has 3 Contrarian Tech Stocks That Look Like Outstanding Buys
Fri, 17 Jun 2016 14:20:46 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook